BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03321630-completion@plaintrial.com
DTSTAMP:20261029T172524Z
DTSTART;VALUE=DATE:20240116
SUMMARY:A Phase II a Study of Lenvatinib\, a Multi-targeted Tyrosine Kinase
  Inhibitor\, Combined With Pembrolizumab (PD-1 Inhibitor) for the Treatmen
 t of Metastatic Gastroesophageal Cancer Patients Who Have Progressed on Fi
 rst or Subsequent Line Therapies — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT03321630
URL:https://plaintrial.com/trial/NCT03321630
END:VEVENT
END:VCALENDAR